All depends on offers and what MK ultimately wants to do. I don’t think he would sell out just to watch all his hard work be swept under the rug and disappear. But money offered can be a big persuasion.
In no way will Radiogel disrupt current cancer market. Radiogel and at least one potential competitor being tested at Duke are niche products that will hopefully gain a place in cancer treatment. Existing treatments that will still have their place. Even in cases of single primary tumor identified early, standard of care will likely involve Radiogel and chemo at a minimum.
News 
Market Data 
Discover 
